ESAF Small Finance Bank jumps after returning to profit in Q1, asset quality improves
ESAF SFB’s net Interest Income (NII) rose 54.7% year-on-year to ₹584.3 crore from ₹377.6 crore. Total income increased to ₹1,346 crore from ₹1,023.4 crore a…
Latest News
Leela Palaces Hotels & Resorts Q1 Results: Profit jumps over five-fold, margins expand
Hotel Leela’s revenue from operations increased 28.1% year-on-year to ₹352 crore from ₹274.8 crore. Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) rose 41.4% to…
Aditya Birla Capital Q1 Results: Lending, insurance lift profit 40%; AUM tops ₹7.5 lakh crore
Aditya Birla Capital reported a 40% jump in June-quarter profit, driven by robust growth across its lending, insurance and housing finance businesses. Its lending portfolio…
GAIL Q1 Results: PSU stock jumps 4% on strong margin expansion; announces Konkan LNG merger
For the June quarter, GAIL posted a net profit of ₹4,292 crore, compared with ₹1,262 crore in the previous quarter. Revenue increased 12% quarter-on-quarter to…
Sun Pharma Q1 Results: Stock falls 3% from highs after US sales miss expectations
Sun Pharma’s Earnings before interest taxes depreciation and amortisation (EBITDA) increased to ₹4,417 crore, compared to street estimates of ₹4,255 crore. The figure turned out…
Market rotation favours quality over momentum; Renaissance’s Pankaj Murarka backs IT, private banks
Pankaj Murarka, CEO and CIO of Renaissance Investment Managers says investors should focus on quality, cash-flow-generating businesses as market leadership shifts. He explains why he…
Divi’s Labs’ share price target raised by 36% by Macquarie; First target above ₹10,000
Macquarie believes the peptide CDMO market is poised for strong medium-term growth, supported by accelerating demand. The brokerage expects the market to expand from nearly…
Lupin shares gain after USFDA nod, launch of generic Sugammadex Injection for neuromuscular blockade reversal
Lupin said its product is bioequivalent to Merck’s Bridion Injection and is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium…
Bajaj Finserv Q1: Net profit rises 18% to ₹6,297 crore; board approves re-insurance business plans
Bajaj Finserv’s Q1 consolidated net profit rose 18% to ₹6,297 crore. NII increased 20% to ₹14,528 crore. The board approved pursuing re-insurance business.
South Korea’s leverage trap and what it means for the Indian markets
India’s retail investors are accumulating debt to buy stocks at high valuations, with margin trading facilities reaching 1.38 trillion rupees. This mirrors South Korea’s leverage…